Jan 26 (Reuters) - The U.S. Food and Drug Administration said on Thursday that AstraZeneca's COVID-19 antibody cocktail Evusheld is not currently authorized for use in the United States until further notice by the agency. (Reporting by Bhanvi Satija in Bengaluru)
U.S. FDA withdraws authorization for AstraZeneca's Evusheld
![Reuters logo](/images/reuters.jpg)